Biotage
Price
Precio
GRÁFICO POR
Preguntas más frecuentes
¿Cuál es el beneficio por acción (BPA) de Biotage?
¿Cuáles son las valoraciones de los analistas y el precio objetivo de las acciones de Biotage?
¿Cuáles son los ingresos de Biotage en los últimos doce meses?
¿Cuál es el EBITDA de Biotage?
¿Cuál es el flujo de caja libre de Biotage?
¿Cuántos empleados tiene Biotage y a qué sector e industria pertenece?
Finanzas
- GPA (TTM)
- 0,323
- Ingresos últimos 12 meses (TTM)
- 197,91 MUS$
- EBITDA (TTM)
- 47,13 MUS$
- Flujo de caja libre (TTM)
- 26,64 MUS$
Calificación de los analistas
El precio objetivo es 14,63 US$ y la acción ha sido analizada por 1 analistas.
Comprar
0
Mantenga
1
Vender
0
Información
Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.
- Empleados
- 673
- Industrias
- Especialidades médicas
- Sector
- Sanidad
Identificador
- Número de Identificación Internacional de Valores (ISIN)
- SE0000454746
- Teletipo de bolsa (ticker) principal
- BIOT